Latest Headlines

1. Volta Labs Expands Long-Read Sequencing Capabilities With Automated Oxford Nanopore Library Prep App On Callisto™ 6/12/2025

   Volta Labs, a genomics applications company, today announced the launch of its Library Prep App for Oxford Nanopore LSK114 on the Callisto™ Sample Prep System. This latest addition to the growing Volta apps menu extends Callisto's footprint in long-read sequencing.

2. Seek Labs Unveils BioSeeker 6/10/2025

   Seek Labs—a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics—today announced BioSeeker, a next-generation AI discovery engine redefining how the world identifies and treats disease.

3. Salimetrics CoreLab+ Expands Access To Dried Blood Spot Testing For Researchers 6/10/2025

   Today, Salimetrics continues its mission to provide tools that support biobehavioral investigators across disciplines, from developmental science to behavioral health, to general health and wellness, and beyond.

4. FUJIFILM Healthcare Europe And IBEX Announce Partnership To Streamline Workflows And Enhance Diagnostic Capabilities In Digital Pathology 6/10/2025

   FUJIFILM Healthcare Europe, the global leader in Digital Pathology software1 and Ibex Medical Analytics (Ibex), a leader in AI-powered cancer diagnostics in Pathology, are delighted to announce a formal partnership to support efficient and accurate cancer diagnosis.

5. Access Medical Labs, A Subsidiary Of Empresas Aries, Completes Historic Lab Expansion With Roche Diagnostics Systems 6/10/2025

   In a milestone rarely achieved in the clinical laboratory industry, Access Medical Labs — the largest private diagnostic lab in Florida — has completed a full transition from Siemens to Roche Diagnostics systems in under 6 months.

6. Svar Life Science And Lablytica Life Science Announce Strategic Partnership To Expand Bioanalytical Services With Advanced LCMS/MS Capabilities 6/10/2025

   Svar Life Science, a leading provider of bioanalytical and diagnostic solutions, is proud to announce a strategic partnership with Lablytica Life Science, a Swedish contract research organization (CRO) specializing in advanced bioanalytical services.

7. Quest Diagnostics To Develop Multi-Cancer Stratification (MCaST) Blood Test Based On MD Anderson Technology 6/10/2025

   Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to improve the assessment of elevated risk of cancer in individuals who would benefit from medically appropriate cancer screenings.

8. Florida Cancer Specialists & Research Institute Launches Liquid Biopsy 6/9/2025

   Liquid biopsy, a blood test that swiftly detects signs of cancerous tumors and cells traveling in the bloodstream, is now available at Florida Cancer Specialists & Research Institute, LLC (FCS), offering significant benefits in the diagnosis and treatment of many of the most common cancers, particularly those in advanced stages.

9. LEX Diagnostics Submits Dual Applications For FDA 510(k) Clearance And CLIA Waiver For Groundbreaking LEX VELO System 6/6/2025

   LEX Diagnostics, a leading innovator in molecular diagnostics, has submitted dual applications to the U.S. Food and Drug Administration (FDA) seeking 510(k) clearance and CLIA waived status for its VELO system, an ultra-fast point-of-care molecular diagnostics platform designed to deliver highly sensitive PCR results for key respiratory pathogens directly from a swab sample in under ten minutes.1

10. Sample Storage Tubes With E-Beam Sterility Assurance 6/5/2025

    Azenta Life Sciences announce a new range of Electron-Beam (E-Beam) treated externally threaded tubes, expanding options for laboratories and biorepositories that desire sterile sample storage solutions.